1 Upcoming events with contributions of the working group

  • Currently none planned.

2 Past events and and all presentation slide decks

15.02.2019: HTA EFSPI SIG 1-day event

Start City Country Type
15.02.2019 Berlin Germany Invited talk

Program

Link to Program

Talks and/or recording

Speaker (click on title to download slides)
Evgeny Degtyarev: Estimands in Oncology

18.03.2019: DAGStat

Start City Country Type
18.03.2019 Munich Germany Contributed talks

Program

Link to Program

29.05.2019: Lifetime Data Science Conference

Start City Country Type
29.05.2019 Pittsburgh USA Contributed talks including EMA discussant

Program

Link to Program

02.06.2019: PSI annual conference

Start City Country Type
02.06.2019 London UK Contributed talks

Program

Link to Program

23.06.2019: DIA Annual meeting

Start City Country Type
23.06.2019 San Diego USA Contributed talk

Program

Link to Program

Talks and/or recording

Speaker (click on title to download slides)
Yi Liu: Estimand Framework and its Impact on Oncology Drug Development: Findings From An Industry Wide Working Group

14.07.2019: ISCB conference

Start City Country Type
14.07.2019 Leuven Belgium Contributed talk

Program

Link to Program

Talks and/or recording

Speaker (click on title to download slides)
Rui Tang: Estimands in the Presence of Treatment Switching

27.07.2019: Joint Statistical Meetings

Start City Country Type
27.07.2019 Denver USA Topic contributed session

Program

Link to Program

23.09.2019: EFSPI Regulatory Statistics Workshop

Start City Country Type
23.09.2019 Basel Switzerland Invited talk

Program

Link to Program

Talks and/or recording

Speaker (click on title to download slides)
Evgeny Degtyarev: Estimand framework: opportunity to rethink some old (and new) problems in Oncology trials?

23.09.2019: ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop

Start City Country Type
23.09.2019 Washington USA Contributed talks (including FDA discussant)

Program

Link to Program

Talks and/or recording

Speaker (click on title to download slides)
Feng Liu: Causal Estimand and Principal Stratum, an Overview and Potential Applications in Oncology
Jiangxiu Zhou: Estimands for PFS2
Alexei C. Ionan (FDA discussant): Estimand Framework in Oncology Drug Development: Challenges and Opportunities

27.09.2019: ESMO

Start City Country Type
27.09.2019 Barcelona Spain Poster

Program

Link to Program

Talks and/or recording

Speaker (click on title to download slides)
Daniel George: Impact of estimand selection on adjuvant treatment outcomes in renal cell carcinoma (RCC)
Bryant Furlow: Commentary on poster

20.10.2019: ISOQoL

Start City Country Type
20.10.2019 San Diego USA Contributed talk

Program

Link to Program

Talks and/or recording

Speaker (click on title to download slides)
Rachael Lawrance: Using PROs in clinical trials: what should I know about?

06.05.2020: Webinar of the Basel Biometrics Section: Impact of COVID-19 on clinical trials

Start City Country Type
06.05.2020 NA Switzerland Invited talk

Program

Link to Program

Talks and/or recording

Speaker (click on title to download slides)
Evgeny Degtyarev: Short overview on COVID-19 from the Cross-Industry Oncology Estimands Working Group

21.05.2020: Estimands in Oncology Virtual Panel Discussion (organized by Cytel)

Start City Country Type
21.05.2020 NA USA Invited talk and panelist

Program

Link to Program

Talks and/or recording

Speaker (click on title to download slides)
Kaspar Rufibach: Estimands in oncology
Michelle Casey: Discussant (no slides)

11.06.2020: PSI Conference Webinar: Impact of COVID-19 to estimands

Start City Country Type
11.06.2020 NA UK Invited talk and panelist

Program

Link to Program

Talks and/or recording

Speaker (click on title to download slides)
Kaspar Rufibach: Application of the estimand framework to assess the impact of COVID-19 on clinical trials

29.06.2020: Webinar of the Basel Biometrics Section: Estimands addendum is final: Anything new for oncology?

Start City Country Type
29.06.2020 NA Switzerland Invited talk

Program

Link to Program

01.08.2020: Joint Statistical Meetings

Start City Country Type
01.08.2020 Philadelphia USA Topic contributed session

Program

Link to Program

Talks and/or recording

Speaker (click on title to download slides)
Jonathan Siegel: Estimand Framework and Its Impact on Drug Development in Oncology
Anja Schiel: Discussant (no slides)
Kunthel By: Discussant FDA (no slides)
Catherine Njue: Discussant from Health Canada (no slides)
Richard J. Cook: Discussant (no slides)

07.09.2020: Webinar of the Basel Biometrics Section: RCTs meeting causal inference: principal stratum strategy and beyond

Start City Country Type
07.09.2020 NA Switzerland Invited talk

Program

Link to Program

Talks and/or recording

Speaker (click on title to download slides)
Kaspar Rufibach: Introduction
Bjoern Bornkamp: Principal Stratum Strategy: Potential Role in Drug Development

22.09.2020: ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop

Start City Country Type
22.09.2020 NA USA Invited talk

Program

Link to Program

Talks and/or recording

Speaker (click on title to download slides)
Jonathan Siegel: Industry Perspective on Subsequent Therapy: An Estimands Approach

05.11.2020: Joint PSI, EFSPI & ASA BIOP Webinar: Estimands

Start City Country Type
05.11.2020 NA UK / USA Invited talk

Program

Link to Program

Talks and/or recording

Speaker (click on title to download slides)
Evgeny Degtyarev: Estimand framework: What are the opportunities in oncology?

17.11.2020: The effective statistician podcast: A deep dive into principal stratification and causal inference

Start City Country Type
17.11.2020 NA Switzerland Discussion

Program

Link to Program

Talks and/or recording

Speaker (click on title to download slides)
Kaspar Rufibach: Link to podcast
Bjoern Bornkamp: Link to podcast

27.11.2020: Working group “Pharmaceutical Industry” of the German Region of the IBS (APF)

Start City Country Type
27.11.2020 NA Germany Invited talk

Program

Link to Program

Talks and/or recording

Speaker (click on title to download slides)
Hannes Buchner: Estimands update: Summary of world-wide authority interaction
Kaspar Rufibach: Estimands update: Summary of world-wide authority interaction

09.12.2020: Deming Conference on Applied Statistics

Start City Country Type
09.12.2020 NA USA Shortcourse

Program

Link to Program

11.02.2021: ASA - FDA - LUNGevity symposium: Statistical considerations in Oncology clinical trials in the COVID-19 era

Start City Country Type
11.02.2021 NA USA Symposium

Program

Link to Program

Talks and/or recording

Speaker (click on title to download slides)
Evgeny Degtyarev: How can the estimand framework support decentralized trials?
Kaspar Rufibach: How can the estimand framework support decentralized trials?

21.04.2021: Duke Industry Statistics Symposium

Start City Country Type
21.04.2021 NA USA Invited talk

Program

Link to Program

Talks and/or recording

Speaker (click on title to download slides)
Natalia Kan-Dobrosky: Estimands in clinical trials with treatment switching

21.09.2021: ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop

Start City Country Type
21.09.2021 NA USA Invited talks and panel discussion

Program

Link to Program

Talks and/or recording

Speaker (click on title to download slides)
Devan Mehrotra: Estimands and Sensitivity Analyses in Clinical Trials - Strengthening Alignment with ICH E9 (R1)
Kaspar Rufibach: Session organizer

21.09.2021: ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop

Start City Country Type
21.09.2021 NA USA Contributed topic session

Program

Link to Program

21.09.2021: ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop

Start City Country Type
21.09.2021 NA USA Contributed topic session

Program

Link to Program

12.10.2021: ISOQoL 2021

Start City Country Type
12.10.2021 NA NA Contributed talk

Program

Link to Program